35.87
price down icon2.07%   -0.76
 
loading
Vaxcyte Inc stock is traded at $35.87, with a volume of 1.14M. It is down -2.07% in the last 24 hours and up +10.10% over the past month. Vaxcyte Inc is a clinical-stage vaccine innovation company engineering high-fidelity vaccines to protect humankind from the consequences of bacterial diseases. It is developing broad-spectrum conjugate and novel protein vaccines to prevent or treat bacterial infectious diseases. Its product comprises of Pneumococcal conjugate vaccine. The firm's product candidate consists of VAX-31, VAX-24, VAX-A1, VAX-PG, VAX-GI, and Others.
See More
Previous Close:
$36.63
Open:
$36.59
24h Volume:
1.14M
Relative Volume:
0.65
Market Cap:
$4.63B
Revenue:
-
Net Income/Loss:
$-507.65M
P/E Ratio:
-7.7978
EPS:
-4.6
Net Cash Flow:
$-616.24M
1W Performance:
+0.65%
1M Performance:
+10.10%
6M Performance:
-61.07%
1Y Performance:
-57.32%
1-Day Range:
Value
$35.77
$36.74
1-Week Range:
Value
$35.25
$37.00
52-Week Range:
Value
$27.66
$121.06

Vaxcyte Inc Stock (PCVX) Company Profile

Name
Name
Vaxcyte Inc
Name
Phone
650-837-0111
Name
Address
825 INDUSTRIAL ROAD, STE. 300, SAN CARLOS, CA
Name
Employee
414
Name
Twitter
Name
Next Earnings Date
2024-11-04
Name
Latest SEC Filings
Name
PCVX's Discussions on Twitter

Compare PCVX with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
Biotechnology icon
PCVX
Vaxcyte Inc
35.87 4.73B 0 -507.65M -616.24M -4.60
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
460.83 120.60B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
558.63 60.80B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
324.79 42.87B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
595.19 36.23B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
294.51 31.54B 3.81B -644.79M -669.77M -6.24

Vaxcyte Inc Stock (PCVX) Upgrades & Downgrades

Date Action Analyst Rating Change
Apr-22-25 Initiated Cantor Fitzgerald Overweight
Dec-20-24 Initiated Goldman Buy
Dec-07-23 Initiated Mizuho Buy
Apr-18-23 Initiated TD Cowen Outperform
Jan-03-23 Reiterated Needham Buy
Dec-15-22 Initiated Guggenheim Buy
Nov-17-22 Initiated BTIG Research Buy
Dec-29-21 Resumed Jefferies Buy
Jun-24-21 Resumed Jefferies Buy
Jul-07-20 Initiated BofA Securities Buy
Jul-07-20 Initiated Cantor Fitzgerald Overweight
Jul-07-20 Initiated Needham Buy
View All

Vaxcyte Inc Stock (PCVX) Latest News

pulisher
Jul 28, 2025

Should I hold or sell Vaxcyte Inc. stock in 2025Best Dividend Insights For Fast Growth - jammulinksnews.com

Jul 28, 2025
pulisher
Jul 28, 2025

What institutional investors are buying Vaxcyte Inc. stockChart Pattern Ideas For Fast Growth - jammulinksnews.com

Jul 28, 2025
pulisher
Jul 28, 2025

What is the risk reward ratio of investing in Vaxcyte Inc. stockInvest smarter with daily stock recommendations - jammulinksnews.com

Jul 28, 2025
pulisher
Jul 28, 2025

What are analysts’ price targets for Vaxcyte Inc. in the next 12 monthsSmart Portfolio Ideas For Fast Growth - jammulinksnews.com

Jul 28, 2025
pulisher
Jul 28, 2025

Is Vaxcyte Inc. stock overvalued or undervaluedBuild wealth steadily with smart trading - jammulinksnews.com

Jul 28, 2025
pulisher
Jul 27, 2025

How strong is Vaxcyte Inc. company’s balance sheetPhenomenal investment performance - jammulinksnews.com

Jul 27, 2025
pulisher
Jul 27, 2025

Is Vaxcyte Inc. a growth stock or a value stockRemarkably fast returns - jammulinksnews.com

Jul 27, 2025
pulisher
Jul 27, 2025

What catalysts could drive Vaxcyte Inc. stock higher in 2025Rapid growth trajectories - jammulinksnews.com

Jul 27, 2025
pulisher
Jul 27, 2025

When is Vaxcyte Inc. stock expected to show significant growthGet insider insights into market trends - jammulinksnews.com

Jul 27, 2025
pulisher
Jul 27, 2025

Is it the right time to buy Vaxcyte Inc. stockCapitalize on fast-moving trading opportunities - jammulinksnews.com

Jul 27, 2025
pulisher
Jul 25, 2025

What analysts say about Vaxcyte Inc. stockExceptional ROI - PrintWeekIndia

Jul 25, 2025
pulisher
Jul 24, 2025

What drives Vaxcyte Inc. stock priceHigh-yield trading alerts - Autocar Professional

Jul 24, 2025
pulisher
Jul 23, 2025

Vaxcyte Inc. Stock Analysis and ForecastRapid market gains - jammulinksnews.com

Jul 23, 2025
pulisher
Jul 23, 2025

Is Vaxcyte Inc. a good long term investmentFree Trading Strategy Suggestions - Autocar Professional

Jul 23, 2025
pulisher
Jul 19, 2025

Mizuho Maintains an Overweight Rating on Vaxcyte (PCVX) - MSN

Jul 19, 2025
pulisher
Jul 19, 2025

Nisa Investment Advisors LLC Buys 293 Shares of Vaxcyte, Inc. (NASDAQ:PCVX) - Defense World

Jul 19, 2025
pulisher
Jul 17, 2025

How the (PCVX) price action is used to our Advantage - news.stocktradersdaily.com

Jul 17, 2025
pulisher
Jul 16, 2025

Vaxcyte’s High-Stakes Bet On Next-Gen Pneumonia Vaccines - Finimize

Jul 16, 2025

Vaxcyte Inc Stock (PCVX) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading
$23.09
price down icon 1.32%
$37.06
price up icon 1.06%
$101.75
price down icon 2.12%
$27.45
price down icon 4.26%
$112.79
price down icon 2.19%
biotechnology ONC
$294.51
price up icon 1.04%
Cap:     |  Volume (24h):